✦ LIBER ✦

Fish oil supplementation in the treatment of major depression: A randomised double-blind placebo-controlled trial

✍ Scribed by Brin F.S. Grenyer; Trevor Crowe; Barbara Meyer; Alice J. Owen; Elizabeth M. Grigonis-Deane; Peter Caputi; Peter R.C. Howe

Book ID: 116841061
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 154 KB
Volume: 31
Category: Article
ISSN: 0278-5846
DOI: 10.1016/j.pnpbp.2007.06.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomised double-blind placebo-controll

Randomised double-blind placebo-controlled trial of fish oil in the treatment of depression

✍ Karen M. Silvers; Cheryl C. Woolley; Frances C. Hamilton; Peter M. Watts; Rosema 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 254 KB

A randomised double blind placebo contro

A randomised double blind placebo controlled trial of fish oil in high risk pregnancy

✍ J. L. Onwude; R. J. Lilford; H. Hjartardottir; A. Staines; D. Tuffnell 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 634 KB

Fish oil in psoriasis—a double-blind ran

Fish oil in psoriasis—a double-blind randomized placebo-controlled trial

✍ S.B. Bittiner; W.F.G. Tucker; S.S. Bleehen 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB

Effects of dietary supplements on depres

Effects of dietary supplements on depressive symptoms in older patients: A randomised double-blind placebo-controlled trial

✍ Salah Gariballa; Sarah Forster 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 413 KB

Clinical trial of adjunctive celecoxib t

Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial

✍ Shahin Akhondzadeh; Sara Jafari; Firoozeh Raisi; Abbas Ali Nasehi; Aboulfazl Gho 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 3 views

A randomised, double-blind, placebo-cont

A randomised, double-blind, placebo-controlled, 5-weeks' study of org 3770 (mirtazapine) in major depression

✍ M. C. Khan 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 433 KB

Fifty-four hospitalised and outpatients with a DSM 111 diagnosis of major depressive disorder and 21-item HPRSD score of 2 18, were randomised to 5 weeks' of treatment with either Org 3770 (n=27; 20-60mg/day) or placebo (n = 27). The treatment with Org 3770 resulted in statistically significant and